Cetera Investment Advisers’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Sell
23,803
-280
-1% -$951 ﹤0.01% 4624
2026
Q1
$42.4K Sell
24,083
-6,717
-22% -$14.6K ﹤0.01% 4595
2025
Q4
$72.4K Sell
30,800
-279
-0.9% -$763 ﹤0.01% 4462
2025
Q3
$95.1K Buy
31,079
+8,285
+36% +$23.7K ﹤0.01% 4337
2025
Q2
$63.6K Buy
22,794
+3,794
+20% +$12.5K ﹤0.01% 3948
2025
Q1
$68.2K Sell
19,000
-160
-0.8% -$643 ﹤0.01% 3826
2024
Q4
$60.4K Buy
19,160
+1,400
+8% +$5K ﹤0.01% 3641
2024
Q3
$50.1K Sell
17,760
-711
-4% -$1.63K ﹤0.01% 3600
2024
Q2
$22.7K Buy
18,471
+554
+3% +$497 ﹤0.01% 3645
2024
Q1
$14.2K Buy
+17,917
New +$16.3K ﹤0.01% 3647

Other funds holding CLOV

Cetera Investment Advisers's CLOV Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Clover Health Investments (CLOV) stake by 1.2% in Q2 2026, selling an estimated $951 and leaving 23,803 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #4624.

Cetera Investment Advisers first reported a position in CLOV in Q1 2024 and has held it in 10 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Cetera Investment Advisers held 23,803 shares of Clover Health Investments worth $125K as of Q2 2026.
  • Cetera Investment Advisers sold 280 Clover Health Investments shares in Q2 2026, an estimated $951.
  • Clover Health Investments made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4624 holding.
  • Cetera Investment Advisers first reported a position in Clover Health Investments in Q1 2024 and has held it in 10 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.